Cita APA (7a ed.)
Jouines, C., Lo Monaco, P., Gaucherot, A., Radermecker, J., Isaac, C., Bourdelais, F., . . . Catez, F. (2025). Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer. Breast Cancer Research, 27(1), 1-22.
Cita Chicago Style (17a ed.)
Jouines, Camille, et al. "Fibrillarin-mediated Ribosomal RNA Maturation Is a Novel Therapeutic Vulnerability in Triple-negative Breast Cancer." Breast Cancer Research 27, no. 1 (2025): 1-22.
Cita MLA (9a ed.)
Jouines, Camille, et al. "Fibrillarin-mediated Ribosomal RNA Maturation Is a Novel Therapeutic Vulnerability in Triple-negative Breast Cancer." Breast Cancer Research, vol. 27, no. 1, 2025, pp. 1-22.
Precaución: Estas citas no son 100% exactas.